Literature DB >> 31721208

Characterization of striatal phenotypes in heterozygous Disc1 mutant mice, a model of haploinsufficiency.

Rathinasamy Baskaran1, Chuan-Ching Lai1, Wai-Yu Li1, Li-Heng Tuan1, Chia-Chuan Wang2, Lukas J-H Lee3, Chih-Min Liu4,5, Hai-Gwo Hwu4,5,6, Li-Jen Lee1,4,5,6.   

Abstract

Disrupted-in-Schizophrenia 1 (DISC1) is a susceptibility gene for several psychiatric illnesses. To study the pathogenesis of these disorders, we generated Disc1 mutant mice by introducing the 129S6/SvEv 25-bp deletion Disc1 variants into the C57BL/6J strain. In this study, we used heterozygous Disc1 mutant (Het) mice to evaluate the DISC1 haploinsufficiency model of schizophrenia. No changes in locomotor behaviors were observed in Het mice; however, after amphetamine injection, greater locomotor activity was observed in Het mice compared with wild-type (WT) mice. Moreover, amphetamine-induced elevations of c-Fos expression and dopamine level in the striatum were greater in Het mice than in WT controls, suggesting an altered dopaminergic regulation in the striatum of Het mice. Compared with those in WTs, the striatal protein levels of dopamine transporter and D2 dopamine receptor were increased in Het mice, while D1 dopamine receptor level was decreased. DISC1 interacting proteins, GSK3α and GSK3β, were downregulated in Het mice, whereas the levels of PDE4B and CREB were not altered. Morphologically, the complexities of striatal median spiny neurons (MSNs), parvalbumin-positive interneurons and Iba1-positive microglia were all decreased in Het mice. The density and head diameter of dendritic spines in the MSNs of Het mice were also reduced. Our results indicate that mice lacking one WT Disc1 allele are more sensitive to psychostimulant amphetamine challenge, which might be attributed to the altered structure and function of the striatal dopaminergic system. Here, we demonstrated striatal phenotypes in heterozygous Disc1 mutant mice, which could be a promising model of DISC1 haploinsufficiency.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  PRID: AB_1240433; PRID: AB_2094832; PRID: AB_477329; PRID: AB_668816; amphetamine; animal model; dendritic spine; dopamine receptor; microglia; neuronal morphology; schizophrenia

Year:  2019        PMID: 31721208     DOI: 10.1002/cne.24813

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  4 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  Opposite Roles of NT-3 and BDNF in Synaptic Remodeling of the Inner Ear Induced by Electrical Stimulation.

Authors:  Qiang Li; Min Chen; Chen Zhang; Tianhao Lu; Shiyao Min; Shufeng Li
Journal:  Cell Mol Neurobiol       Date:  2020-08-08       Impact factor: 5.046

3.  Altered White Matter and Layer VIb Neurons in Heterozygous Disc1 Mutant, a Mouse Model of Schizophrenia.

Authors:  Shin-Hwa Tsai; Chih-Yu Tsao; Li-Jen Lee
Journal:  Front Neuroanat       Date:  2020-12-15       Impact factor: 3.856

4.  Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model.

Authors:  Chuan-Ching Lai; Rathinasamy Baskaran; Chih-Yu Tsao; Li-Heng Tuan; Pei-Fen Siow; Mahalakshmi Palani; Lukas Jyuhn-Hsiarn Lee; Chih-Min Liu; Hai-Gwo Hwu; Li-Jen Lee
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.